Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Acadia Healthcare Company (ACHC) Share-based Compensation (2016 - 2025)

Acadia Healthcare Company (ACHC) has disclosed Share-based Compensation for 15 consecutive years, with $6.4 million as the latest value for Q4 2025.

  • On a quarterly basis, Share-based Compensation fell 36.43% to $6.4 million in Q4 2025 year-over-year; TTM through Dec 2025 was $31.7 million, a 14.59% decrease, with the full-year FY2025 number at $31.7 million, down 14.59% from a year prior.
  • Share-based Compensation was $6.4 million for Q4 2025 at Acadia Healthcare Company, up from $6.1 million in the prior quarter.
  • In the past five years, Share-based Compensation ranged from a high of $12.5 million in Q4 2021 to a low of $6.1 million in Q3 2025.
  • A 5-year average of $8.4 million and a median of $8.4 million in 2023 define the central range for Share-based Compensation.
  • Peak YoY movement for Share-based Compensation: skyrocketed 100.13% in 2021, then crashed 37.16% in 2022.
  • Acadia Healthcare Company's Share-based Compensation stood at $12.5 million in 2021, then crashed by 37.16% to $7.9 million in 2022, then increased by 16.98% to $9.2 million in 2023, then grew by 9.57% to $10.1 million in 2024, then plummeted by 36.43% to $6.4 million in 2025.
  • Per Business Quant, the three most recent readings for ACHC's Share-based Compensation are $6.4 million (Q4 2025), $6.1 million (Q3 2025), and $10.5 million (Q2 2025).